Consensus Ovintiv Inc. Börse Stuttgart

Equities

47Q

US69047Q1022

Market Closed - Börse Stuttgart 15:20:29 2024-05-15 EDT 5-day change 1st Jan Change
45.92 EUR +0.59% Intraday chart for Ovintiv Inc. -6.07% +16.42%

Evolution of the average Target Price on Ovintiv Inc.

Price target over the last 5 years

History of analyst recommendation changes

d77f47d4f415a459106df8f1b9e4cda._oRhpdjUs227788VsLziqOIdOgZBiBajaP_nZg1ldvg.yPA47-iT2EDYupdf2vCmwI9XdH8jvFXsHqCOI1RcHJKh6zXi9b7fWPeVpA~b828f9b7ad6140c66b028ce1aa85857f
Ovintiv Insider Sold Shares Worth $600,000, According to a Recent SEC Filing MT
Ovintiv Maintained at Buy at UBS Following First-Quarter Results; Price Target Raised to US$70.00 MT
UBS Adjusts Ovintiv Price Target to $70 From $69, Maintains Buy Rating MT
Mizuho Securities Raises Price Target on Ovintiv to $64 From $58, Keeps Buy Rating MT
Ovintiv's Price Target Raised to US$62 from US$60 by RBC Capital Markets MT
RBC Raises Price Target on Ovintiv to $62 From $60, Keeps Sector Perform Rating MT
Ovintiv Maintained at Sector Perform at RBC Following Q1 Results; Price Target Kept at US$60.00 MT
Ovintiv Maintained at Outperform at National Bank Following First-Quarter Results; Price Target Kept at US$68.00 MT
Ovintiv Maintained at Buy at TPH Following First-Quarter Results; Price Target at US$66.00 MT
Ovintiv Receives Sector Perform Rating from RBC Capital Markets Ahead of Q1 Results MT
Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating MT
Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 MT
UBS Raises Ovintiv Price Target to $69 From $62, Maintains Buy Rating MT
RBC Raises Price Target on Ovintiv to $61 From $49, Keeps Sector Perform Rating MT
Goldman Sachs Adjusts Ovintiv's Price Target to $56 From $47, Keeps Neutral Rating MT
Mizuho Securities Trims Price Target on Ovintiv to $58 From $59, Maintains Buy Rating MT
Citigroup Raises Price Target on Ovintiv to $58 From $52, Keeps Buy Rating MT
Wells Fargo Raises Price Target on Ovintiv to $54 From $44, Maintains Equalweight Rating MT
UBS Raises Ovintiv Price Target to $62 From $57, Maintains Buy Rating MT
Ovintiv Maintained at Buy at UBS Following Q4 Results; Price Target Raised to US$62.00 MT
RBC Lifts Price Target on Ovintiv to $49 From $48 After 'Strong' Q4, Keeps Sector Perform Rating MT
Ovintiv Maintained at Buy at TPH Following Q4 Results; Price Target Kept at US$62.00 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
49.98 USD
Average target price
62.58 USD
Spread / Average Target
+25.21%
High Price Target
71 USD
Spread / Highest target
+42.06%
Low Price Target
52.74 USD
Spread / Lowest Target
+5.52%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ovintiv Inc.

Mizuho Securities
RBC Capital Markets
Tudor Pickering Holt & Co.
National Bank Financial
Morgan Stanley
UBS
Goldman Sachs
Citigroup
Wells Fargo Securities
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW